Narrative review / 2019
EFSA concluded nicotinamide riboside chloride is safe up to 300 mg/day for healthy adults, excluding pregnant/lactating women who are safe up to 230 mg/day.
The EFSA NDA Panel evaluated the safety and bioavailability of nicotinamide riboside chloride as a novel food in supplements. Animal and human data indicated that it contributes to the nicotinamide body pool and human studies do not raise safety concerns. The Panel concluded that the novel food is safe under proposed use levels up to 300 mg/day for the healthy adult population, excluding pregnant and lactating women. For pregnant and lactating women, an intake up to 230 mg/day was concluded to be safe.
- Study type
- Scientific opinion / risk assessment
- Who was studied
- Healthy adults (excluding pregnant and lactating women) and pregnant/lactating women
- What was measured
- Safety and bioavailability of nicotinamide riboside chloride in food supplements
THE PAPER
Safety of nicotinamide riboside chloride as a novel food pursuant to Regulation (EU) 2015/2283 and bioavailability of nicotinamide from this source, in the context of Directive 2002/46/EC.
EFSA Panel on Nutrition, Novel foods and Food allergens (NDA), Turck D, Castenmiller J, de Henauw S, Hirsch-Ernst KI, Kearney J, Maciuk A, Mangelsdorf I, McArdle HJ, Naska A, Pelaez C, Pentieva K, Siani A, Thies F, Tsabouri S, Vinceti M, Cubadda F, Engel KH, Frenzel T, Heinonen M, Marchelli R, Neuhäuser-Berthold M, Pöting A, Poulsen M, Sanz Y, Schlatter JR, van Loveren Agnès de Sesmaisons-Lecarré H, Germini A, Knutsen HK. EFSA J, 2019.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.